Beeline Medicines has formally launched with $300 million in Series A financing, led by Bain Capital, and a pipeline of drugs for immunology and inflammation therapies licensed from Bristol Myers ...
Bristol Myers Squibb’s growth portfolio is offsetting declines in older products as planned, even as star heart drug Camzyos ...
Bristol Myers Squibb reported a first-quarter profit that beat Wall Street expectations on Thursday, helped by ...
Bristol Myers Squibb has called time on a bispecific antibody partnership with Zymeworks that the Big Pharma inherited from ...
From September 1, battery management system, DC-DC converter & vehicle control unit must be indigenously made. The move aims ...
The move aims at reducing dependence on imported parts and building a robust domestic electric vehicle industry ...
There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...
Melton was formally recognized during the 2026 ISM Awards Gala on April 27 at ISM World, ISM's annual international supply chain conference.
Bristol-Myers Squibb's growth portfolio nears 60% of total revenues, growing 16% YoY, effectively offsetting patent cliff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results